Abstract
A number of evolving clinical indications for cutting balloon angioplasty (CBA) have been described in the clinical literature, including angioplastyresistant stenoses, in-stent restenosis, ostial lesions and small vessel disease. Methods. We analyzed the Mayo Clinic PTCA registry and report procedural and in-hospital clinical outcomes in 100 patients (103 procedures, 114 lesions) undergoing CBA. Results. CBA was successfully completed in 109 lesions (96%). The majority of lesions (73%) required additional treatment with either balloon angioplasty (39%) or stent implantation (34%). Severe intimal dissection resulting in at least 50% luminal obstruction occurred in 13 lesions (11%). A single incident of branch occlusion was documented, resulting in ST elevation myocardial infarction. There were no incidents of vessel perforation, urgent percutaneous or surgical target vessel revascularization, or in-hospital death. Conclusion. CBA is feasible and safe, with a low incidence of procedural complications and in-hospital adverse cardiac events when used primarily for in-stent restenosis.
Original language | English (US) |
---|---|
Pages (from-to) | 720-724 |
Number of pages | 5 |
Journal | Journal of Invasive Cardiology |
Volume | 14 |
Issue number | 12 |
State | Published - Dec 2002 |
Keywords
- Dissection
- Perforation
- Restenosis
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging
- Cardiology and Cardiovascular Medicine